Braskem (BAK) Financials

$3.74 +0.05 (+1.36%)

As of 03:58 PM Eastern

Annual Income Statements for Braskem

This table shows Braskem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-2,067	-1,008	-162	2,500	-1,413	-682	750	1,197	-534	758
Consolidated Net Income / (Loss)	-1,949	-1,008	-155	2,504	-1,351	-657	739	1,182	-224	697
Net Income / (Loss) Continuing Operations	-1,949	-1,009	-162	2,504	-1,351	-657	739	1,178	-445	696
Total Pre-Tax Income	-2,868	-1,278	2.27	3,222	-1,864	-1,145	929	1,589	-213	1,115
Total Operating Income	-1,455	-2,076	-246	3,518	-1,090	-1,528	1,072	1,545	553	1,740
Total Gross Profit	970	623	2,149	5,750	2,159	1,603	2,944	3,950	3,897	2,572
Total Revenue	12,518	13,392	17,301	18,947	11,271	13,019	14,947	14,873	12,653	11,840
Operating Revenue	12,518	13,392	17,301	18,947	11,271	13,019	14,947	14,873	12,653	11,840
Total Cost of Revenue	13,149	14,485	16,554	14,555	11,587	13,488	12,921	12,407	10,023	9,269
Operating Cost of Revenue	13,149	14,485	16,554	14,555	11,587	13,488	12,921	12,407	10,023	9,269
Total Operating Expenses	824	983	992	874	774	1,059	954	920	2,077	560
Selling, General & Admin Expense	749	904	922	821	726	997	897	870	827	277
Research & Development Expense	75	79	71	53	48	62	57	51	50	43
Total Other Income / (Expense), net	-1,430	799	248	-296	-774	383	-143	44	-765	-625
Interest & Investment Income	278	346	260	284	116	212	152	182	221	148
Other Income / (Expense), net	-1,708	453	-12	-579	-890	171	-295	-138	-987	26
Income Tax Expense	-919	-268	164	717	-514	-488	190	411	-	419
Net Income / (Loss) Attributable to Noncontrolling Interest	118	-	-	4.13	62	25	-10	-15	98	61
Basic Earnings per Share	($6.89)	-	-	$35.73	($25.23)	($6.38)	-	-	-	-
Weighted Average Basic Shares Outstanding	797.21M	797.21M	797.21M	796.31M	797.22M	451.67M	451.67M	797.26M	-	-
Diluted Earnings per Share	($6.89)	-	-	$35.68	($25.20)	($6.37)	-	-	-	-
Weighted Average Diluted Shares Outstanding	797.21M	797.21M	797.21M	796.31M	797.22M	451.67M	451.67M	797.26M	-	-
Weighted Average Basic & Diluted Shares Outstanding	797.21M	797.21M	797.21M	796.31M	797.22M	451.67M	451.67M	797.26M	-	-

No quarterly income statements for Braskem are available.

This table details how cash moves in and out of Braskem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-67	-834	711	-1,117	3,209	-5,483	117	-2,823	-1,149	-1,017
Net Cash From Operating Activities	533	86	1,883	564	3,734	-4,652	1,176	-1,847	260	-52
Net Cash From Continuing Operating Activities	533	86	1,883	564	3,734	-4,652	1,176	-1,847	260	-52
Net Income / (Loss) Continuing Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation Expense	800	1,073	895	749	779	904	771	884	825	537
Non-Cash Adjustments To Reconcile Net Income	-309	-1,404	952	-751	3,151	-5,782	48	-2,312	507	-802
Changes in Operating Assets and Liabilities, net	41	417	35	566	-196	226	358	-419	-1,072	213
Net Cash From Investing Activities	-599	-919	-917	-606	-525	-664	-673	-674	-795	-843
Net Cash From Continuing Investing Activities	-599	-919	-917	-606	-525	-664	-673	-674	-795	-843
Purchase of Property, Plant & Equipment	-608	-934	-917	-614	-531	-667	-697	-686	-795	-843
Sale of Property, Plant & Equipment	9.06	15	0.38	7.18	6.38	3.13	25	12	0.17	0.32
Net Cash From Financing Activities	-0.97	-1.44	-255	-1,075	-0.46	-166	-387	-302	-614	-122
Net Cash From Continuing Financing Activities	-0.97	-1.44	-255	-1,075	-0.46	-166	-387	-302	-614	-122
Payment of Dividends	-0.97	-1.44	-255	-1,075	-0.46	-166	-387	-302	-614	-122
Cash Interest Paid	689	732	550	517	527	557	494	650	562	-473

No quarterly cash flow statements for Braskem are available.

This table presents Braskem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Total Assets	16,425	18,907	16,657	16,604	16,573	16,952	15,155	15,921	15,930
Total Current Assets	5,989	7,716	6,519	7,048	6,582	5,820	5,421	5,259	4,886
Cash & Equivalents	2,423	2,924	2,358	1,557	2,669	1,693	1,430	1,140	2,060
Short-Term Investments	301	1,050	464	633	705	421	615	696	369
Accounts Receivable	703	771	749	1,459	1,001	722	909	1,078	558
Inventories, net	2,213	2,583	2,654	2,930	1,614	1,897	2,187	2,005	1,721
Current Deferred & Refundable Income Taxes	222	301	219	256	230	418	218	-	254
Plant, Property, & Equipment, net	0.00	0.00	0.00	6,677	6,917	8,041	8,185	8,986	9,018
Total Noncurrent Assets	3,853	3,216	2,906	2,802	3,022	3,092	1,534	1,352	1,300
Long-Term Investments	71	34	28	14	11	18	20	3.12	37
Noncurrent Note & Lease Receivables	88	100	36	68	48	70	53	45	65
Intangible Assets	548	641	572	516	545	687	706	823	863
Noncurrent Deferred & Refundable Income Taxes	2,529	1,610	1,509	1,706	1,849	1,284	690	352	335
Other Noncurrent Operating Assets	617	831	761	499	569	1,033	64	128	-
Total Liabilities & Shareholders' Equity	16,425	18,907	16,657	16,604	16,573	16,952	15,155	15,921	15,930
Total Liabilities	15,908	16,486	13,611	13,221	12,675	13,482	9,596	9,684	10,203
Total Current Liabilities	4,572	5,048	4,575	4,519	5,465	4,035	5,867	5,605	7,052
Short-Term Debt	2,677	2,584	2,248	2,444	1,111	2,503	197	366	798
Accounts Payable	3,067	3,179	2,616	2,461	2,005	2,500	2,310	1,611	2,158
Current Employee Benefit Liabilities	167	171	157	210	157	155	166	-	50
Other Taxes Payable	101	80	93	182	183	80	111	461	173
Other Current Liabilities	296	478	408	251	356	360	70	56	8.93
Total Noncurrent Liabilities	12,545	13,184	10,926	10,972	11,852	11,935	7,831	8,664	8,319
Long-Term Debt	8,256	8,316	6,511	6,084	7,888	7,069	6,268	6,696	6,374
Capital Lease Obligations	535	609	606	445	445	498	23	-	-
Asset Retirement Reserve & Litigation Obligation	137	226	222	207	-	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	293	390	347	599	293	109	138	320	7.41
Noncurrent Employee Benefit Liabilities	89	117	93	87	91	97	53	59	-
Other Noncurrent Operating Liabilities	290	338	311	251	145	109	85	116	407
Total Equity & Noncontrolling Interests	-692	676	1,156	1,113	-744	982	1,457	1,652	529
Total Preferred & Common Equity	-773	823	1,385	1,411	-424	1,216	1,683	1,902	842
Total Common Equity	-694	923	1,132	780	-430	1,216	1,683	1,902	842
Common Stock	1,301	1,658	1,522	1,355	1,454	1,880	1,947	2,281	2,472
Retained Earnings	-2,269	-564	0.00	-	-872	0.00	-66	-66	-
Accumulated Other Comprehensive Income / (Loss)	272	-176	-393	-569	-1,003	-1,184	-1,449	-1,560	-1,943
Other Equity Adjustments	2.10	5.56	3.22	0.62	0.00	532	1,264	1,262	328
Noncontrolling Interest	82	-147	-230	-298	-320	-234	-226	-250	-313

No quarterly balance sheets for Braskem are available.

This table displays calculated financial ratios and metrics derived from Braskem's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.53%	-22.59%	-8.69%	68.10%	-13.43%	-12.90%	0.50%	17.55%	6.86%	0.00%
EBITDA Growth	-329.18%	-186.32%	-82.71%	407.16%	-164.91%	-129.28%	-32.45%	486.34%	-83.03%	0.00%
EBIT Growth	-94.84%	-530.06%	-108.77%	248.40%	-45.90%	-274.61%	-44.77%	424.30%	-124.57%	0.00%
NOPAT Growth	29.93%	-108.30%	540.59%	458.40%	28.67%	-225.41%	-25.54%	195.95%	-64.35%	0.00%
Net Income Growth	-93.38%	-548.88%	-106.20%	285.43%	-105.58%	-188.88%	-37.48%	627.45%	-132.15%	0.00%
EPS Growth	0.00%	0.00%	0.00%	241.58%	-295.41%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Growth	521.47%	-95.45%	233.55%	-84.88%	180.27%	-495.58%	163.66%	-811.13%	598.37%	0.00%
Free Cash Flow Firm Growth	-54.78%	-104.22%	913.44%	522.93%	123.44%	-209.66%	882.04%	101.67%	0.00%	0.00%
Invested Capital Growth	33.41%	-17.49%	-77.15%	2.65%	-10.78%	6.20%	-6.42%	10.03%	0.00%	0.00%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	7.75%	4.65%	12.42%	30.35%	19.15%	12.32%	19.70%	26.56%	30.80%	21.72%
EBITDA Margin	-18.87%	-4.11%	3.69%	19.46%	-10.65%	-3.48%	10.36%	15.41%	3.09%	19.45%
Operating Margin	-11.62%	-15.50%	-1.42%	18.57%	-9.67%	-11.74%	7.17%	10.39%	4.37%	14.70%
EBIT Margin	-25.27%	-12.12%	-1.49%	15.51%	-17.57%	-10.42%	5.20%	9.46%	-3.43%	14.92%
Profit (Net Income) Margin	-15.57%	-7.53%	-0.90%	13.22%	-11.98%	-5.05%	4.95%	7.95%	-1.77%	5.89%
Tax Burden Percent	67.96%	78.88%	-6,841.67%	77.74%	72.44%	57.36%	79.57%	74.38%	105.45%	62.53%
Interest Burden Percent	90.66%	78.70%	-0.88%	109.65%	94.16%	84.40%	119.53%	112.95%	48.98%	63.13%
Effective Tax Rate	0.00%	0.00%	7,233.34%	22.26%	0.00%	0.00%	20.43%	25.88%	0.00%	37.61%
Return on Invested Capital (ROIC)	-46.94%	-70.68%	289.12%	28.09%	-7.49%	-10.23%	8.13%	11.08%	7.86%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-89.66%	-31.62%	-69.75%	25.68%	-13.32%	-5.76%	6.86%	11.47%	-5.26%	0.00%
Return on Net Nonoperating Assets (RNNOA)	24,415.22%	-39.39%	-302.82%	1,331.43%	-1,131.61%	-43.65%	39.41%	97.32%	-92.62%	0.00%
Return on Equity (ROE)	24,368.28%	-110.07%	-13.69%	1,359.51%	-1,139.10%	-53.88%	47.54%	108.40%	-84.76%	0.00%
Cash Return on Invested Capital (CROIC)	-75.56%	-51.51%	414.74%	25.47%	3.91%	-16.24%	14.76%	1.52%	-192.14%	0.00%
Operating Return on Assets (OROA)	-17.90%	-9.13%	-1.55%	17.71%	-11.81%	-8.45%	5.00%	8.84%	-2.72%	0.00%
Return on Assets (ROA)	-11.03%	-5.67%	-0.93%	15.10%	-8.06%	-4.09%	4.76%	7.42%	-1.41%	0.00%
Return on Common Equity (ROCE)	-348,778.58%	-123.53%	-11.55%	1,292.24%	-3,773.16%	-64.04%	54.81%	136.37%	-134.89%	0.00%
Return on Equity Simple (ROE_SIMPLE)	252.03%	-122.50%	-11.21%	177.50%	318.54%	-54.05%	43.92%	62.15%	-26.63%	0.00%
Net Operating Profit after Tax (NOPAT)	-1,018	-1,453	17,516	2,734	-763	-1,070	853	1,145	387	1,086
NOPAT Margin	-8.14%	-10.85%	101.24%	14.43%	-6.77%	-8.22%	5.71%	7.70%	3.06%	9.17%
Net Nonoperating Expense Percent (NNEP)	42.73%	-39.06%	358.87%	2.41%	5.84%	-4.47%	1.27%	-0.40%	13.12%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-9.45%	-11.93%	166.50%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	105.04%	108.16%	95.68%	76.82%	102.80%	103.60%	86.45%	83.42%	79.21%	78.28%
SG&A Expenses to Revenue	5.98%	6.75%	5.33%	4.33%	6.44%	7.66%	6.00%	5.85%	6.53%	2.34%
R&D to Revenue	0.60%	0.59%	0.41%	0.28%	0.43%	0.47%	0.38%	0.34%	0.39%	0.36%
Operating Expenses to Revenue	6.58%	7.34%	5.74%	4.62%	6.87%	8.13%	6.38%	6.19%	16.42%	4.73%
Earnings before Interest and Taxes (EBIT)	-3,163	-1,623	-258	2,938	-1,980	-1,357	777	1,407	-434	1,766
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-2,363	-550	638	3,688	-1,201	-453	1,548	2,292	391	2,303
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	3.81	3.24	10.77	0.00	2.41	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	12.43	6.54	31.82	0.00	5.54	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.12	0.26	0.21	0.44	0.16	0.22	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	3.36	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	12.85%	0.00%	19.09%	9.44%	3.82%	9.61%	4.52%
Earnings Yield	0.00%	0.00%	0.00%	29.74%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.15	5.85	4.41	1.51	0.78	0.99	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.82	0.81	0.58	0.79	0.67	0.82	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	15.60	4.03	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.57	5.44	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	19.32	126.79	5.28	26.36	2.01	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.40	6.00	18.90	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-16.58	17.03	8.10	8.06	-12.69	10.26	4.45	4.27	13.56	0.00
Long-Term Debt to Equity	-12.71	13.21	6.16	5.87	-11.19	7.71	4.32	4.05	12.05	0.00
Financial Leverage	-272.29	1.25	4.34	51.85	84.93	7.57	5.75	8.48	17.62	0.00
Leverage Ratio	-2,208.95	19.42	14.66	90.05	141.38	13.17	9.99	14.60	30.12	0.00
Compound Leverage Factor	-2,002.62	15.28	-0.13	98.74	133.12	11.11	11.95	16.49	14.75	0.00
Debt to Total Capital	106.42%	94.45%	89.02%	88.97%	108.56%	91.12%	81.66%	81.04%	93.13%	0.00%
Short-Term Debt to Total Capital	24.84%	21.21%	21.37%	24.24%	12.77%	22.65%	2.48%	4.20%	10.36%	0.00%
Long-Term Debt to Total Capital	81.58%	73.24%	67.65%	64.73%	95.78%	68.47%	79.18%	76.84%	82.78%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.76%	-1.21%	-2.18%	-2.96%	-3.68%	-2.12%	-2.84%	-2.87%	-4.06%	0.00%
Common Equity to Total Capital	-6.44%	7.58%	10.76%	7.74%	-4.94%	11.00%	21.18%	21.83%	10.93%	0.00%
Debt to EBITDA	-4.85	-20.91	14.68	2.43	-7.87	-22.22	4.19	3.08	18.35	0.00
Net Debt to EBITDA	-3.67	-13.63	10.21	1.84	-5.05	-17.52	2.86	2.28	12.04	0.00
Long-Term Debt to EBITDA	-3.72	-16.21	11.16	1.77	-6.94	-16.70	4.06	2.92	16.31	0.00
Debt to NOPAT	-11.26	-7.92	0.53	3.28	-12.38	-9.42	7.61	6.16	18.53	0.00
Net Debt to NOPAT	-8.52	-5.16	0.37	2.48	-7.94	-7.42	5.19	4.56	12.16	0.00
Long-Term Debt to NOPAT	-8.63	-6.14	0.41	2.39	-10.92	-7.08	7.38	5.85	16.47	0.00
Altman Z-Score	0.09	0.68	1.29	2.29	0.38	0.76	0.00	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	1,531.28%	-12.24%	15.69%	4.95%	-231.24%	-18.86%	-15.30%	-25.80%	-59.15%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.31	1.53	1.42	1.56	1.20	1.44	0.92	0.94	0.69	0.00
Quick Ratio	0.75	0.94	0.78	0.81	0.80	0.70	0.50	0.52	0.42	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,639	-1,059	25,126	2,479	398	-1,698	1,549	158	-9,462	0.00
Operating Cash Flow to CapEx	88.93%	9.33%	205.39%	93.08%	711.37%	-700.25%	174.76%	-273.92%	32.68%	-6.18%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.07
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.12
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.71	0.75	1.04	1.14	0.67	0.81	0.96	0.93	0.79	0.00
Accounts Receivable Turnover	16.98	17.62	15.67	15.41	13.09	15.97	15.05	18.19	22.68	0.00
Inventory Turnover	5.48	5.53	5.93	6.41	6.60	6.60	6.16	6.66	5.82	0.00
Fixed Asset Turnover	0.00	0.00	0.00	2.79	1.51	1.60	1.74	1.65	1.40	0.00
Accounts Payable Turnover	4.21	5.00	6.52	6.52	5.14	5.61	6.59	6.58	4.64	0.00
Days Sales Outstanding (DSO)	21.49	20.71	23.29	23.69	27.89	22.86	24.26	20.07	16.10	0.00
Days Inventory Outstanding (DIO)	66.57	65.98	61.56	56.98	55.31	55.26	59.21	54.80	62.66	0.00
Days Payable Outstanding (DPO)	86.69	73.01	55.98	56.00	70.95	65.08	55.38	55.44	78.60	0.00
Cash Conversion Cycle (CCC)	1.37	13.68	28.88	24.67	12.24	13.04	28.08	19.43	0.16	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,480	1,859	2,253	9,863	9,608	10,769	10,141	10,836	9,849	0.00
Invested Capital Turnover	5.77	6.51	2.86	1.95	1.11	1.25	1.43	1.44	2.57	0.00
Increase / (Decrease) in Invested Capital	621	-394	-7,610	255	-1,161	629	-696	988	9,849	0.00
Enterprise Value (EV)	10,293	10,870	9,947	14,879	7,522	10,632	0.00	0.00	0.00	0.00
Market Capitalization	1,539	3,516	3,663	8,407	1,783	2,928	0.00	0.00	0.00	0.00
Book Value per Share	($0.87)	$1.16	$1.42	$0.98	($0.95)	$2.69	$3.73	$2.39	$0.00	$0.00
Tangible Book Value per Share	($1.56)	$0.35	$0.70	$0.33	($2.16)	$1.17	$2.16	$1.35	$0.00	$0.00
Total Capital	10,776	12,185	10,520	10,086	8,700	11,051	7,946	8,714	7,701	0.00
Total Debt	11,468	11,509	9,365	8,973	9,445	10,070	6,489	7,062	7,172	0.00
Total Long-Term Debt	8,791	8,925	7,116	6,529	8,333	7,567	6,291	6,696	6,374	0.00
Net Debt	8,673	7,501	6,514	6,770	6,060	7,938	4,425	5,222	4,706	0.00
Capital Expenditures (CapEx)	599	919	917	606	525	664	673	674	795	843
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,370	1,279	1,369	2,784	-1,145	2,174	-2,294	-1,816	-3,797	0.00
Debt-free Net Working Capital (DFNWC)	4,094	5,253	4,191	4,974	2,229	4,288	-249	20	-1,368	0.00
Net Working Capital (NWC)	1,417	2,668	1,943	2,529	1,117	1,785	-446	-346	-2,166	0.00
Net Nonoperating Expense (NNE)	930	-446	17,672	230	588	-413	114	-37	611	388
Net Nonoperating Obligations (NNO)	3,172	1,183	1,098	8,751	10,353	9,788	8,683	9,184	9,320	0.00
Total Depreciation and Amortization (D&A)	800	1,073	895	749	779	904	771	884	825	537
Debt-free, Cash-free Net Working Capital to Revenue	10.95%	9.55%	7.91%	14.69%	-10.16%	16.70%	-15.35%	-12.21%	-30.01%	0.00%
Debt-free Net Working Capital to Revenue	32.71%	39.22%	24.23%	26.25%	19.77%	32.93%	-1.67%	0.14%	-10.82%	0.00%
Net Working Capital to Revenue	11.32%	19.92%	11.23%	13.35%	9.91%	13.71%	-2.99%	-2.33%	-17.12%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($6.89)	($17.24)	($1.26)	$18.15	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	797.21M	797.21M	797.21M	796.31M	797.22M	451.67M	451.67M	797.26M	0.00	0.00
Adjusted Diluted Earnings per Share	($6.89)	($17.24)	($1.26)	$18.10	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	797.21M	797.21M	797.21M	796.31M	797.22M	451.67M	451.67M	797.26M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	797.21M	797.21M	797.21M	796.31M	797.22M	451.67M	451.67M	797.26M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-1,018	-1,453	-172	2,734	-763	-1,070	853	1,145	387	1,086
Normalized NOPAT Margin	-8.14%	-10.85%	-0.99%	14.43%	-6.77%	-8.22%	5.71%	7.70%	3.06%	9.17%
Pre Tax Income Margin	-22.91%	-9.54%	0.01%	17.00%	-16.54%	-8.80%	6.22%	10.69%	-1.68%	9.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.21
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.36
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.16
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.30
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-0.05%	-0.14%	-164.43%	42.92%	-0.03%	-25.33%	52.29%	25.51%	-274.00%	17.47%
Augmented Payout Ratio	-0.05%	-0.14%	-164.43%	42.92%	-0.03%	-25.33%	52.29%	25.51%	-274.00%	17.47%

No quarterly metrics and ratios for Braskem are available.

Frequently Asked Questions About Braskem's Financials

When does Braskem's financial year end?

According to the most recent income statement we have on file, Braskem's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Braskem's net income changed over the last 9 years?

Braskem's net income appears to be on an upward trend, with a most recent value of -$1.95 billion in 2024, falling from $697.14 million in 2015. The previous period was -$1.01 billion in 2023. Find out what analysts predict for Braskem in the coming months.

What is Braskem's operating income?

Braskem's total operating income in 2024 was -$1.45 billion, based on the following breakdown:

Total Gross Profit: $969.76 million
Total Operating Expenses: $823.58 million

How has Braskem revenue changed over the last 9 years?

Over the last 9 years, Braskem's total revenue changed from $11.84 billion in 2015 to $12.52 billion in 2024, a change of 5.7%.

How much debt does Braskem have?

Braskem's total liabilities were at $15.91 billion at the end of 2024, a 3.5% decrease from 2023, and a 55.9% increase since 2016.

How much cash does Braskem have?

In the past 8 years, Braskem's cash and equivalents has ranged from $1.14 billion in 2017 to $2.92 billion in 2023, and is currently $2.42 billion as of their latest financial filing in 2024.

How has Braskem's book value per share changed over the last 9 years?

Over the last 9 years, Braskem's book value per share changed from 0.00 in 2015 to -0.87 in 2024, a change of -87.1%.

Related Companies

This page (NYSE:BAK) was last updated on 5/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Braskem (BAK) Financials

Frequently Asked Questions About Braskem's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Braskem (BAK) Financials

Annual Income Statements for Braskem

Quarterly Income Statements for Braskem

Annual Cash Flow Statements for Braskem

Quarterly Cash Flow Statements for Braskem

Annual Balance Sheets for Braskem

Quarterly Balance Sheets for Braskem

Annual Metrics And Ratios for Braskem

Quarterly Metrics And Ratios for Braskem

Frequently Asked Questions About Braskem's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools